PRF Technologies Ltd.
PRFXNasdaq
$1.19
↑ +0.8%Jul 17 close · end-of-day
Price
1Y↓ -83.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$771,087.87
Enterprise Value
-$2.4M
P/E
—
P/S
45.4
P/B
0.1
EV/EBITDA
—
PEG
—
FCF Yield
-513.2%
Dividend Yield
—
Revenue (TTM)
$17,000.00
Net Income (TTM)
-$5.0M
Free Cash Flow (TTM)
-$4.0M
Gross Margin
—
Operating Margin
-30129.4%
Net Margin
-29541.2%
ROE
-58.8%
ROIC
-74.7%
Debt / Equity
—
Net Cash
$3.1M
Return 1Y
-84.0%
Company profile
PainReform Ltd. engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair.
- CEO
- Ilan Hadar
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 4
- Website
- painreform.com
Earnings
No reported earnings periods on file.
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $17,000.00 |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.7M | -$7.2M | -$8.9M | -$9.6M | -$14.7M | -$5.1M |
| Net income | -$4.1M | -$7.2M | -$8.8M | -$9.3M | -$14.6M | -$5.0M |
| Diluted EPS | -$1.25 | -$7.25 | -$63.46 | -$122.94 | -$105.52 | -$7.47 |
| Operating cash flow | -$2.6M | -$6.6M | -$6.5M | -$6.7M | -$12.6M | -$4.0M |
| Free cash flow | -$2.6M | -$6.6M | -$6.5M | -$6.7M | -$12.6M | -$4.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | -30129.4% |
| Net margin | — | — | — | — | — | -29541.2% |
No quarterly data.
Company news
Jun 25, 2026
May 29, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.